Haemonetics Corporation, commonly referred to as Haemonetics, is a leading global healthcare company headquartered in the United States. Founded in 1971, the company has established itself as a key player in the blood management industry, focusing on innovative solutions for blood collection, processing, and transfusion. With major operational regions across North America, Europe, and Asia, Haemonetics serves hospitals and blood centres worldwide.
The company’s core products include blood collection systems, automated blood processing equipment, and software solutions that enhance the efficiency and safety of blood management. Haemonetics is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in the healthcare sector. Notable achievements include a strong market presence and a reputation for advancing transfusion medicine, making Haemonetics a vital contributor to improving patient outcomes globally.
+9 vs industry average
Haemonetics’s score of 31 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Haemonetics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Haemonetics's reported carbon emissions
In 2025, Haemonetics reported total emissions of approximately 31,010,000 kg CO2e, comprising 3,101,000 kg CO2e from Scope 1 and 18,376,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Over the past few years, Haemonetics has shown a trend of fluctuating emissions, with 2024 emissions at approximately 36,550,000 kg CO2e and 2023 emissions at about 38,420,000 kg CO2e. Despite these figures, Haemonetics has not set specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. The company is not currently part of any significant climate initiatives such as the Science Based Targets initiative (SBTi) or similar pledges. Haemonetics operates from the US and is focused on improving its corporate responsibility, although specific details on future emissions reduction strategies remain unclear.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Haemonetics’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Haemonetics yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Haemonetics
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project